Skip to main content
Caplight Logo









Chengdu Zeling Biomedical Technology Co. Ltd.

Chengdu Zeling Biomedical Technology Co. Ltd.

Private
ChengduHealthcare & Life Scienceshttps://zelingbiomed.com

Last Round

Series C

Jan 12, 2026

Total Funding Raised

$185.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Chengdu Zeling Biomedical Technology Co. Ltd. is a biotechnology company that focuses on the research and development of innovative drug candidates, particularly small molecule inhibitors for the treatment of cancer and inflammatory, autoimmune, and neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

small-molecule inhibitorsdrug discoveryai drug discoveryoncology therapeuticsPARP-1 inhibitorsRIPK1 inhibitorsNLRP3 inhibitorspreclinical developmentin silico drug designbiotechautoimmune disease therapeuticsmolecular generationdrug pipelinepharma licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Chengdu Zeling Biomedical Technology Co. Ltd. Comparables

Compare Chengdu Zeling Biomedical Technology Co. Ltd. with similar companies based on industry and business-model similarity.

Chengdu Zeling Biomedical Technology Co. Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Accro Bioscience Inc.
81%
Sironax
81%
Ventus Therapeutics
77%

Chengdu Zeling Biomedical Technology Co. Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJan 12, 2026
Series B ExtensionAug 5, 2025
Series BNov 24, 2023
Series ADec 8, 2021

Chengdu Zeling Biomedical Technology Co. Ltd. Investors

Notable investors and investment history

Chengdu Zeling Biomedical Technology Co. Ltd. investors
InvestorRounds
Lanchi VenturesSeries C
Tencent ExplorationSeries C
True Light CapitalSeries C
Sichuan Innovation Development Investment Management Co., Ltd.Series B
Huajin CapitalSeries C, Series B
5Y CapitalSeries C, Series B Extension
Shenzhen New Henglida Capital ManagementSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 12, 2026

    $86M round led by True Light Capital and Qiming Venture Partners.

  • Dec 8, 2021

    Raised $17M with participation from Shenzhen New Henglida Capital Management.

Chengdu Zeling Biomedical Technology Co. Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Chengdu Zeling Biomedical Technology Co. Ltd. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersChengdu
Year Founded2018
Last FundingJan 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?